About Vaasavaa Pharmaceuticals Private Limited
Data last updated:
Vaasavaa Pharmaceuticals Private Limited is a private limited company based in Solapur, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 17 July 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN2000PTC015122. Its GSTIN is 27AABCV5177B1ZE (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.42 Cr. It is led by directors including Narasimha Rao Polavarapu and Murali Krishna Prasad Koneru.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No C – 216 MIDC Chincholiarea, Solapur, Maharashtra, India – 413255.
As per the financials filed for FY 2025, the company reported a revenue of ₹59.28 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹1.79 Cr (net margin 3%) and EBITDA of ₹4.85 Cr (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 10% over five years.
The company has about 67 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Vaasavaa Pharmaceuticals. As per MCA filings, the company has open charges of ₹9.61 Cr and satisfied charges of ₹13.5 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vaasavaa.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No C – 216 MIDC Chincholiarea, Solapur, Maharashtra, India – 413255
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Vaasavaa Pharmaceuticals Private Limited
Vaasavaa Pharmaceuticals operates one associated brand: Vaasavaa Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures Active Pharmaceutical Ingredients and drug intermediates for domestic and international markets. | vaasavaa.com |
Business Activity of Vaasavaa Pharmaceuticals Private Limited
The main business activity of Vaasavaa Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vaasavaa Pharmaceuticals Private Limited FY 2025 filings available
Vaasavaa Pharmaceuticals Private Limited reported revenue of ₹59.28 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Vaasavaa Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 16% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vaasavaa Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.85 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.79 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vaasavaa Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vaasavaa Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Vaasavaa Pharmaceuticals Private Limited
Vaasavaa Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narasimha Rao Polavarapu | Director | 23 Jun 2003 | 23 Years 3 Months | Current |
| Murali Krishna Prasad Koneru | Director | 17 Jul 2000 | 26 Years 3 Months | Current |
| Sri Ram Dhanekula | Director | 04 Jul 2013 | 13 Years 3 Months | Current |
| Subbarao Chandraskhar Rao Movva | Director | 17 Jul 2000 | 26 Years 3 Months | Current |
Peer Comparison of Vaasavaa Pharmaceuticals Private Limited
Vaasavaa Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cadchem Laboratories Limited | ₹59.73 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Chandigarh, India |
| Macsen Labs Limited | ₹59.7 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Udaipur, Rajasthan, India |
| Bhasya International Private Limited | ₹59.51 Cr (FY 2024) | •••• | •••• | 124.0% | •••• | Hyderabad, Telangana, India |
| Myjoy Pharmaceuticals Private Limited | ₹59.43 Cr (FY 2025) | •••• | •••• | -81.0% | •••• | Kolkata, West Bengal, India |
| Parb Pharmaceuticals Private Limited | ₹59.42 Cr (FY 2025) | •••• | •••• | 2461.0% | •••• | Dehradun, Uttarakhand, India |
| Vaasavaa Pharmaceuticals Private Limited this company | ₹59.28 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Solapur, Maharashtra, India |
| Venus Chemicals and Drugs Private Limited | ₹59.13 Cr (FY 2025) | •••• | •••• | 66.0% | •••• | Hyderabad, Telangana, India |
| Vivachem Intermediates Private Limited | ₹59.12 Cr (FY 2025) | •••• | •••• | 84.0% | •••• | Raikot, Punjab, India |
| Glochem Industries Private Limited | ₹58.99 Cr (FY 2023) | •••• | •••• | -62.0% | •••• | Hyderabad, Telangana, India |
| Unichemie International Private Limited | ₹58.91 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Keshava Organics Pvt Ltd | ₹58.68 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Vaasavaa Pharmaceuticals by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vaasavaa Pharmaceuticals Private Limited
Vaasavaa Pharmaceuticals Private Limited is audited by ASHOK MADGUNDI AND COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASHOK MADGUNDI AND COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Vaasavaa Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vaasavaa Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 2021 | Yes Bank Limited | ₹9.61 Cr | Open |
| 28 Feb 2021 | Others | ₹29.98 Lakh | Satisfied |
| 16 Jul 2020 | Others | ₹71.32 Lakh | Satisfied |
| 28 Mar 2019 | Others | ₹25 Lakh | Satisfied |
| 07 Oct 2013 | Andhra Bank | ₹20 Lakh | Satisfied |
Total charge records: 6 View all charges
Legal Cases of Vaasavaa Pharmaceuticals Private Limited
Vaasavaa Pharmaceuticals Private Limited has 4 court cases on record: 1 filed by Vaasavaa Pharmaceuticals, 3 filed against it. 1 case is pending and 3 are disposed. Status as checked between 02 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 3 | 1 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed by the company against Discovery Laboratories Private Limited | Pending |
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed against the company by Nine Labs Pvt., Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Cases SS) | Filed against the company by M-S.Super Chemicals | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Vaasavaa Pharmaceuticals Private Limited
Vaasavaa Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 3 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Vaasavaa Pharmaceuticals Private Limited
Vaasavaa Pharmaceuticals Private Limited has a workforce of 67 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vaasavaa Pharmaceuticals Private Limited
Vaasavaa Pharmaceuticals Private Limited has 5 board changes on record since 2000: 4 appointments and 1 cessation. The latest: Sri Ram Dhanekula ceased to be Additional Director on 30 Sep 2014.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vaasavaa Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vaasavaa Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vaasavaa Pharmaceuticals Private Limited
Vaasavaa Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCV5177B1ZE | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vaasavaa Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vaasavaa Pharmaceuticals Private Limited
Vaasavaa Pharmaceuticals is an active private limited company based in Solapur, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 17 July 2000 (26+ years old) and is registered under CIN U24232PN2000PTC015122.
Vaasavaa Pharmaceuticals reported revenue of ₹59.28 Cr for FY 2025 (up 16% YoY).
Vaasavaa Pharmaceuticals has 4 current directors:
- Narasimha Rao Polavarapu - Director
- Murali Krishna Prasad Koneru - Director
- Sri Ram Dhanekula - Director
- Subbarao Chandraskhar Rao Movva - Director
Vaasavaa Pharmaceuticals reported a net profit of ₹1.79 Cr (net margin 3%) and EBITDA of ₹4.85 Cr (EBITDA margin 8.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vaasavaa Pharmaceuticals is -8% over three years and 10% over five years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vaasavaa Pharmaceuticals is 27AABCV5177B1ZE, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Vaasavaa Pharmaceuticals is U24232PN2000PTC015122. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vaasavaa Pharmaceuticals has 4 court cases on record: 1 filed by the company and 3 filed against it. 1 is pending.
Vaasavaa Pharmaceuticals was incorporated on 17 July 2000, making it 26+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Vaasavaa Pharmaceuticals by revenue are Cadchem Laboratories Limited, Macsen Labs Limited, Bhasya International Private Limited, Myjoy Pharmaceuticals Private Limited, Parb Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals).
Sri Ram Dhanekula ceased to be Additional Director on 30 Sep 2014. Sri Ram Dhanekula was appointed as Director on 04 Jul 2013. Narasimha Rao Polavarapu was appointed as Director on 23 Jun 2003. Vaasavaa Pharmaceuticals has 5 board changes on record in total.
Vaasavaa Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 3 overdue payments to 1 micro and small supplier. The latest return was filed on 01 Nov 2019.